Report Overview

The UK Neurology Devices Market size stood at USD xx million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of 8% during the forecast period.

The key factors propelling the growth of the market there are huge investments made by the private players in neurology devices, increase in R&D in the field of neurotherapies, and rising of the aging population. The growth of the neurology devices market in UK is also attributed to the increasing incidence of neurological disorders that include brain aneurysms, brain tumors, epilepsy, memory disorders, multiple sclerosis, Parkinsons disease, peripheral neuropathy, post-herpetic neuralgia, spinal cord tumor, and stroke. In addition, with the increasing healthcare spending, increasing investment by medical device manufactures, and increasing neurological disease prevalence are expected to drive the overall Neurology Devices market growth in UK.



Market Growth Drivers

The growth of neurological devices is being driven through an emphasis on developing superior neuromodulation and neurostimulation techniques, leveraging minimally invasive procedures that benefit patients. This has resulted in companies investing more in R&D, to better treat and rehabilitate the brain. As number of geriatric populations is expected to increase in coming years who are more prone to disorders such as cognitive impairment and dementia which ultimately rises the growth of market in near future. Increasing demand for minimally invasive therapy, rising prevalence of urinary bladder diseases, and technological advancements such as the introduction of novel coatings and engineering strategies are the main factors driving the growth of the market.